NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-424 Cr | ₹-298 Cr | ₹-150 Cr | ₹-61 Cr | ₹-96 Cr |
What is the latest Cash Flow from Investing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-424 Cr |
| Mar2025 | ₹-298 Cr |
| Mar2024 | ₹-150 Cr |
| Mar2023 | ₹-61 Cr |
| Mar2022 | ₹-96 Cr |
How is Cash Flow from Investing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-424 Cr | Negative | |
| Mar2025 | ₹-298 Cr | Negative | |
| Mar2024 | ₹-150 Cr | Negative | |
| Mar2023 | ₹-61 Cr | Negative | |
| Mar2022 | ₹-96 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,215.6 Cr | -4.5% | -11.5% | 28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -4.5% |
-11.5% |
28.6% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses